MMP-13 inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 2, 2005-02 ,pp. : 237-241

Informa Healthcare

Access to resources Recommend Favorite

Phospholipase A₂ inhibitors for the treatment of inflammatory diseases: a patent review (2010 – present)

By Magrioti Victoria   Kokotos George  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 3, 2013-03 ,pp. : 333-344

Informa Healthcare

Access to resources Recommend Favorite

New Hope for the Treatment of Osteoarthritis Through Selective Inhibition of MMP-13

By  

Current Medicinal Chemistry, Vol. 18, Iss. 7, 2011-03 ,pp. : 977-1001

Bentham Science Publishers

Access to resources Recommend Favorite

A Quantitative Structure-Activity Relationship Study on a Series of Selective Non-zinc Binding Inhibitors of MMP13

By  

Medicinal Chemistry, Vol. 10, Iss. 2, 2014-03 ,pp. : 174-188

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Synthesis and Biological Evaluation of New 1,3-diphenyl-3- (phenylamino)propan-1-ones as Selective Cyclooxygenase (COX-2) Inhibitors

By  

Medicinal Chemistry, Vol. 14, Iss. 7, 2018-11 ,pp. : 652-659

Bentham Science Publishers

Access to resources Recommend Favorite